Global Hydrogel-based Drug Delivery System Market: Industry Analysis and Forecast (2019-2027)
Global Hydrogel-based Drug Delivery System Market size was valued at US$ 6300 Mn in 2019 and the total revenue is expected to grow at 7.6% through 2019 to 2027, reaching nearly US$ 10600 Mn in the forecast period.
Global Hydrogel-based Drug Delivery System Market Overview:
Hydrogel-based drug delivery system is used in various applications due to its spatial and temporal control over the release of various therapeutic agents, like small-molecule drugs, macromolecular drugs, and cells. Hydrogen-based drug delivery system is widely preferred due to its tunable physical properties, controlled degradation, capacity to protect the labile drug from degradation, hydrogels serve as a platform in which various physiochemical interactions with the encapsulated drug are controlled their release.
To know about the Research Methodology :- Request Free Sample Report
The report has covered the market trends from 2015 to forecast the market through 2026. 2019 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.
Global Hydrogel-based Drug Delivery System Market Dynamics:
Hydrogel-based drug delivery system absorbs small to large drug molecules like (Non-Steroidal Anti-inflammatory Drugs) NSAID, peptide, protein. Due to this property hydrogen-based drug delivery system is widely used in achieving drug delivery. The driving factor of the market is biocompatibility and biodegradable properties with the controlled-release mechanism. This factor is anticipated to fuel the growth of the market.
A wider no. of research activities is being carried out on COVID-19 for developing vaccines using hydrogels and this factor is estimated to boost the market of hydrogel-based drug delivery systems. As the COVID-19 pandemics are growing and to date, there is no proper medicine available for the virus.
Hydrogel formulating drug molecules is responsible to deliver a controlled drug release system and these factors are helping the system in dose sparing, lower Side effects reduce the frequency of drug administration. These factors are responsible to offer improved patient compliance and ease in production and self-application. Further, rising funding and investments in the research and development in novel drug delivery systems, target drug delivery, and diagnostics is one of the major factors driving the growth of the market.
Moreover, a market expansion for generating more revenue is likely to fuel the growth of the market. For example, in January 2020, Ferring B.V. received approval from the Ministry of Health, Labour, and welfare Japan to commercialize their newly launched hydrogen-based drug delivery device for cervical ripening. This launch is likely to grab more attention in the market.
Global Hydrogel-based Drug Delivery System Market Segment Analysis:
The Natural segment is considered to supplement the growth of the Global Hydrogel-based Drug Delivery System Market
The natural segment is dominating the global hydrogel-Based drug delivery system and accounted for 30.6% in 2020. The segment is classified based on the polymer that is natural, synthetic, and hybrid moreover proteins like collagen, lysosome, and gelatin and polysaccharides such as alginate, hyaluronic acid, and chitosan. As the molecules have better hydrogen binding and natural hydrogens in the chemical structure.
Hydrogel-based drug delivery systems are generally made from a type of polymer called a synthetic polymer. As synthetic polymers are responsible to offer a wide range of benefits like higher drug absorption, better mechanical properties, enhanced life-space, and sustainable degradation feature. Some of the drugs belonging to this category are Poly (vinyl pyrrolidone), and Poly (vinyl pyrrolidone) starch these drugs are widely used and are boosting the demand for synthetic polymers.
Further, the amalgamation of Natural and synthetic polymer is likely to fuel the growth of the market. And this concept is known as the high version of SMART hydrogel. These SMART hydrogels are based on the stimulus generated by the body. That may be in the chemical form or physical form. Physical stimuli like temperature sensitivity, pressure, magnetic, and electric field enabling for target drug delivery. These factors are likely to propel the growth of the market in the forecast period.
Global Hydrogel-based Drug Delivery System Market
The ocular segment is dominating the delivery route segment of the Global Hydrogel-based Drug Delivery System Market:
The ocular segment is likely to gain more market share of 39.4% in the forecast period. The growth of the segment is attributed to the widespread application of hydrogel in ocular drug delivery applications. As most of the contact lenses are hard and made from hydrogen film and offer easy application of therapeutic drugs into contact lenses. Moreover, huge clinical trials of ocular therapeutics are boosting the growth of the market in the forecast period.
For example, Massachusetts eye and ear infirmaries are conducting clinical trials on dexamethasone releasing contact lenses which were developed in hydrogen-based contact lense. And demonstrated the safety and efficacy of dex-lense in a rabbit model. As a result, Dex-Lense inhibited sture-induced corneal neovascularization and inflammation for 7 days
The subcutaneous drug delivery segment is second dominating in the segment with a CAGR of 9.1% during the forecast period. As hydrogel is a biodegradable material, they are largely used in subcutaneous drug delivery system.
Global Hydrogel-based Drug Delivery System Market Regional Insights:
Global Hydrogel-based Drug Delivery System Market Regional Insights is segmented into North America, Asia Pacific, Europe, Latin America, Middle East, and Africa.
North America is leading in the Hydrogel-based Drug Delivery System market with 45.7% of market share in 2020 due to the efficient compensation. In addition, mergers, acquisitions, and the launching of new products are likely to boost the growth of the market. Ocular Therapeutix™ announced the development of a hydrogel ocular implant that is responsible to deliver tyrosine kinase inhibitors for controlled drug delivery systems in the US. Further, the OTX-TKI implant containing a 600ug dose has entered the 1st clinical trial phase
Asia Pacific is gaining a significant market share with the highest CAGR of 16.3% during the forecast period. Moreover, rising population and improving healthcare facilities with easy access are likely to boost the growth of the market. Further, increasing demand for cut healthcare expenses is likely to boost the growth of the market. The dominating countries of Asia Pacific are India, China, and Japan due to the presence of prominent market players in the region.
Global Hydrogel-based Drug Delivery System Market
The objective of the report is to present a comprehensive analysis of the Global Hydrogel-based Drug Delivery System Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Global Hydrogel-based Drug Delivery System Market dynamics, structure by analyzing the market segments and project the Global Hydrogel-based Drug Delivery System Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Hydrogel-based Drug Delivery System Market make the report investor’s guide.
For more information of visit:https://www.maximizemarketresearch.com/market-report/global-hydrogel-based-drug-delivery-system-market/115760/
Global Hydrogel-based Drug Delivery System Market Scope: Inquire before buying
Global Hydrogel-based Drug Delivery System Market
Global Hydrogel-based Drug Delivery System Market, by Region
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
o Colombia
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
Global Hydrogel-based Drug Delivery System Market Key Player
• GALDERMA
• Blairex Laboratories, Inc.
• Johnson & Johnson
• Bausch and Lomb
• Medtronic
• Ocular Therapeutix, Inc.
• Ferring B.V.
• Endo International plc
• Akorn, Incorporated
• Tolmar Pharmaceuticals, Inc
Maximize Market Research offers customization of reports according to the specific requirement of our clients.
This Report Is Submitted By : Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
